Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) shares dropped 1.4% on Thursday . The stock traded as low as C$0.35 and last traded at C$0.36. Approximately 76,850 shares were traded during mid-day trading, an increase of 56% from the average daily volume of 49,351 shares. The stock had previously closed at C$0.36.
Nanalysis Scientific Price Performance
The firm’s 50 day moving average price is C$0.39 and its two-hundred day moving average price is C$0.41. The stock has a market cap of C$40.70 million, a PE ratio of -3.00 and a beta of 0.72. The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.11.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Recommended Stories
- Five stocks we like better than Nanalysis Scientific
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Battle of the Retailers: Who Comes Out on Top?
- What Is WallStreetBets and What Stocks Are They Targeting?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
